Can what you eat help calm psoriasis, a chronic inflammatory disease that affects the skin? It's identified by the development of thick, red patches with silvery scales, causing the area to itch or ...

Scott Gottlieb, MD, discusses the real-world outcomes of tildrakizumab for moderate to severe plaque psoriasis.

Evidence from multiple trials links weight loss with milder symptoms and improved wellbeing in people with psoriasis.

Consuming a greater proportion of nutrients from plant sources may aid management of psoriasis symptoms, according to a new study.

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and ...

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

Why aren't we talking about it more?

In this video interview, James Song, MD, FAAD, Co-CMO spoke about his presentation from Maui Derm 2026 on what’s new with current therapies for psoriasis.

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

Portia has not taken Sotyktu. Portia Brown* has long been drawn toward helping people cope with challenges. Since volunteering as a college student to work with her peers to educate them about sexual ...